Free Sanofi Patient Assistance Form in PDF

Free Sanofi Patient Assistance Form in PDF

The Sanofi Patient Assistance form is a comprehensive document designed to connect eligible U.S. residents with certain prescription medications and vaccines at no cost through the Sanofi Patient Connection® program. This assistance is aimed at those who meet specific eligibility requirements, including financial criteria. If you think you might qualify and need help accessing your medication, consider filling out the form by clicking the button below.

Get Form

In today's healthcare landscape, the cost of prescription medications and vaccines can pose a significant barrier, preventing many individuals from accessing the treatments they need to live healthy lives. Recognizing this challenge, Sanofi Patient Connection® offers a lifeline to eligible US residents facing financial barriers that hinder their access to necessary Sanofi prescription medications and vaccines. Through the Patient Assistance Connection segment of this program, participants may receive select Sanofi prescription medications and vaccines at no cost, provided they meet certain eligibility criteria related to residency, healthcare supervision, income, insurance status, and age for vaccines. The application process is designed to be straightforward: complete the application form, secure the necessary signatures, and submit it through specified channels. However, ensuring all information is correct and complete is crucial, as any missing details could delay the application process. Beyond immediate access to medications, the program offers additional support services to address broader needs that could be beneficial for applicants. This comprehensive approach underlines Sanofi Cares North America's commitment to not just alleviating the financial burden of medication costs but also to supporting the overall well-being of its applicants.

Preview - Sanofi Patient Assistance Form

APPLICATION

Sanofi Patient Connection® is a program (the “Program”) to help you get access to the medications and resources you need at no cost. Patient Assistance Connection is part of the Program that provides select Sanofi prescription medications and vaccines, at no cost, if you meet certain eligibility requirements. Patient Assistance Connection is made possible through Sanofi Cares North America.

Who may be eligible for Patient Assistance Connection?

In order to be eligible for this portion of the Program, you must meet the following requirements:

You must be a resident of the U.S. or the U.S. territories and be under the care of a licensed healthcare provider authorized to prescribe, dispense and administer medicine in the U.S.

You must have an annual household income of [≤400%] of the current Federal Poverty Level. If you may be eligible for Medicaid, you will be required to provide documentation of Medicaid denial before being assessed for patient assistance eligibility.

If you are enrolled in Medicare Part D, you may also be eligible based on the income criteria noted above.

You must have no insurance coverage or, for commercially insured patients, have no access to the prescribed product or treatment via your insurance.

For Vaccines, you must be 19 years of age or older (except for IMOVAX® Rabies and IMOGAM® Rabies-HT).

How do I apply?

Complete page 2, sign page 3, then bring or send the form to your healthcare provider to complete and sign page 4. Missing information may delay processing of your application. Your completed application may be submitted by your healthcare provider as follows:

U.S. Mail

Fax

Secure Provider Portal*

Sanofi Patient Connection

1.888.847.1797

www.visitspconline.com

PO Box 222138

 

*Excluding Mozobil® and Thymoglobulin®

Charlotte, NC 28222-2138

 

What happens next?

When we receive your application, we will review it to see if you qualify for Patient Assistance Connection. If you are eligible:

1.You and your healthcare provider will receive a letter notifying you of enrollment. If you are a Medicare Part D patient, your plan sponsor will also receive a letter notifying it of your enrollment.

2.You will be enrolled for 12 months. If you are a Medicare Part D patient, you will be enrolled through the end of the calendar year.

3.Your medication will be sent directly to your healthcare provider’s office in approximately 5-7 business days from when you are approved.

If you do not qualify for Patient Assistance Connection, we will send you and your healthcare provider a letter with the reason for denial.

Do not include Patient Medical Records with this application.

© 2021 Sanofi US Services, Inc.

 

P: 1.888.847.4877 · F: 1.888.847.1797

1 of 5

P.O. Box 222138 · Charlotte, NC · 28222-2138

MAT-US-2109597-v1.0-11/2021

 

 

APPLICATION

1. PATIENT INFORMATION

First Name

Gender

 M  F

Phone

MI

DOB

 

Email Address

Last Name

SSN

 

Primary Language

Address

 

 

 

City

State

 

Zip Code

Household Size

 1  2  3  4  5  Other:

 

Annual Household

 

Income

 

 

 

I permit Sanofi Patient Connection to speak with the following person and/or organization about the information on this application and the status of my application request.

Patient Representative/Organization Name

Relationship to Patient

Phone

2. PATIENT INSURANCE INFORMATION

Insurance?

Yes

No

If yes, is it Medicare Part D?

Yes

No

Primary Insurance

 

 

 

Secondary Insurance

 

 

Policy #

 

 

Group #

Policy #

 

Group #

Policyholder Name

 

 

 

Policyholder Name

 

 

DOB

 

 

 

DOB

 

 

Insurance Phone

 

 

 

Insurance Phone

 

 

3. RESOURCE CONNECTION

Do you want the Program to help identify resources provided by other organizations?

Please note: You will receive a separate call from a Program associate with contact information for helpful resources checked on your application.

If yes, please mark which resources you may be interested in if available:

Yes (PATIENT SIGNATURE FOR AUTHORIZATION IN SECTION 4 REQUIRED)

No

 Clinical Support Services  Transportation Information

 Health Supplies

 Nutritional Supplements (groceries, food banks, etc.)

 Home Care Services (shelter, utilities, etc.)

 Other (Please Elaborate):

 

Do not include Patient Medical Records with this application.

© 2021 Sanofi US Services, Inc.

 

P: 1.888.847.4877 · F: 1.888.847.1797

2 of 5

P.O. Box 222138 · Charlotte, NC · 28222-2138

MAT-US-2109597-v1.0-11/2021

 

 

APPLICATION

4. PATIENT AUTHORIZATION (REQUIRED)

Please read the following carefully, then date and sign where indicated below.

Income Verification: Sanofi Patient Connection and its authorized third party agents will use my date of birth or social security number and/or additional demographic information as needed to access my credit information and information derived from public and other sources to estimate my income in conjunction with the eligibility determination process. As a soft credit inquiry, this option will not impact my credit score . Sanofi Patient Connection and its authorized third party agents reserve the right to ask for additional documents and information at any time.

I state that the information and documents provided in connection with this application are complete and accurate. I agree to immediately inform a Program representative and my Doctor/ Healthcare Provider if my income or insurance status changes during the course of my participation in this Program.

HIPAA Consent: I authorize my healthcare providers and staff; my health insurer, health plan or programs that provide me health benefits (together, “Health Insurers”) to disclose to, Sanofi US, its affiliated companies (i.e. Sanofi Pasteur U.S. and Genzyme, a Sanofi Comp any), Sanofi Cares North America, and authorized third party agents involved in administration of this Program, (collectively “Program Sponsor”), health information about me, including information related to my medical condition, treatment, health insurance coverage, claims, prescriptions and referral to and enrollment in this Program for purposes of determining my participation in, and administering, the Program, which may include contacting me as well as my Doctor/Healthcare Provider, office/hospital staff, insurer (public/private) or others. I understand a representative from Sanofi may contact me for follow-up on any adverse event I may report regarding a Sanofi product. I authorize and consent to release of identifiable information about me including medical, financial and insurance records and information as required for participation in the Program. I understand that identifiable information about me will be kept confidential and will not be further used or disclosed except to administer the Program, or as required by law. I understand that information I authorize to be disclosed may be re-disclosed and is no longer protected by Federal privacy regulations. I agree that this authorization is voluntary and that I may refuse to sign this authorization. Refusal to sign will not affect my ability to obtain treatment but I will not be able to participate in this Program. Unless revoked, this authorization shall remain in effect throughout my participation in the Program, including subsequent reapplication as required. I may withdraw this authorization at any time by written notification to my Doctor/Healthcare Provider; however, withdrawal of authorization will terminate my participation in this Program and will not affect information already disclosed under this Authorization.

I understand that it is my responsibility to follow-up with my prescriber or the Program to make sure that my re-orders, as appropriate, are requested in a timely manner by my Provider so I do not run out of medication. I understand that Sanofi US and Sanofi Cares North America reserve the right at any time and without notice to modify or change eligibility criteria or discontinue this Program.

Patient Authorization (REQUIRED)

By signing below, I acknowledge that I have read and agree to the Patient Authorization to

Use and Disclose Health Information above.

 

Patient/Representative Signature (REQUIRED)

 

Printed Name

Date

5. PATIENT CONSENT

Please read the following carefully, then date and sign where indicated below.

I authorize the Program to contact me by mail, telephone, or e-mail, with information about the Program, disease state and products, promotions, services, and research studies, and to ask my opinion about such information and topics, including market research and disease-related surveys. I further authorize the Program to de-identify my health information and use it in performing research, including linkage with other de-identified information the Program receives from other sources, education, business analytics, marketing studies, or for other commercial purposes. I understand that entities operating or administering parts of the Program may share identifiable health information with one another in order to de-identify it for these purposes and as needed to perform the Services or to send the communications listed above (the “Communications”). I understand and agree that the Program may use my health information for these purposes and may share my health information with my doctors, specialty pharmacies, and insurers. I understand that I may be contacted by the Program in the event that I report an adverse event associated with a Sanofi product.

I understand that I do not have to opt in to receive the Communications, and that I can still receive patient assistance through the Program, as prescribed by my physician. I may opt out of receiving Communications offered by the Program, at any time by notifying a Program representative by telephone at 1-800- 633-1610 or by mailing a letter to Sanofi US Customer Services, P.O. Box 5925 Mailstop 55A-220A5, Bridgewater, NJ 08807-5925. I also understand that the Services may be revised, changed, or terminated at any time.

Patient Consent

By signing below, I acknowledge that I have read and agree to the Patient Consent above.

Patient/Representative Signature

 

Printed Name

Date

Do not include Patient Medical Records with this application.

© 2021 Sanofi US Services, Inc.

 

P: 1.888.847.4877 · F: 1.888.847.1797

3 of 5

P.O. Box 222138 · Charlotte, NC · 28222-2138

MAT-US-2109597-v1.0-11/2021

 

 

APPLICATION

6. TO BE COMPLETED BY THE HEALTHCARE PROVIDER (HCP)

Please check the appropriate box (prescriber and patient signature required for all applications)

Patient Assistance

Benefits Verification (BV) and Patient

 BV only

No cost medication program. Check this

Assistance

Insurance coverage research program.

box if patient does not have health

Insurance coverage research and no cost

Check this box if only insurance coverage

insurance coverage.

medication program. Check this box if the

research is desired.

 

patient has insurance coverage.

 

7. TREATMENT AND PRESCRIBING INFORMATION

Patient Name

 

 

DOB

 

 

Medication #1

 

 

Medication #2

 

 

ICD-10 Code

 

 

ICD-10 Code

 

 

 Vials

 Pens

 N/A

 Vials

 Pens

 N/A

Dosage (# of units per day)

 

Dosage (# of units per day)

 

Qty

 

 

Qty

 

 

8. PRESCRIBER INFORMATION

Prescriber Name

 

 

State Where

 

 

Licensed

 

 

 

License #

NPI #

Tax ID #

DEA #

Facility Name

 

 

 

Facility Address*

 

 

 

City

 

State

Zip Code

Office Contact Name

 

Title/Role

 

Primary Phone

 

Primary Fax

Primary Email

*Sanofi product must be shipped to the signing prescriber’s office or hospital address authorized by the prescriber and not to a 3rd party.

I certify that the information provided is current, complete, and accurate to the best of my knowledge. I certify that the Sanofi product is medically necessary for this patient and that I am authorized under State law to prescribe and dispense the requested medication. I certify that I have obtained from my patient all required written authorization for the release of my patient’s personal identification, medical and insurance information to Sanofi US and/or Sanofi Cares North America and their agents and representatives. I understand that any information provided is for the sole use of the Program to verify my patient’s insurance coverage, to assess, if applicable, patient’s eligibility for participation in the Patient Assistance Program and to otherwise administer the Sanofi Patient Connection Program and related services. I understand that I am under no obligation to prescribe any Sanofi product and that I have not received, nor will I receive, any benefit from Sanofi or their agents or representatives for prescribing a Sanofi product. The facility address noted above in Section 8 is my office or hospital address. My signature certifies that any prescription products received from this Program will be used for the above-named patient only and will not be resold nor offered for sale, trade or barter and will not be returned for credit, nor will payment be sought from any payer, patient or other source for product received from the Program.

Prescriber Signature (REQUIRED – no stamps)

SIGN

HERE

Printed Name

Date

Do not include Patient Medical Records with this application.

© 2021 Sanofi US Services, Inc.

 

P: 1.888.847.4877 · F: 1.888.847.1797

4 of 5

P.O. Box 222138 · Charlotte, NC · 28222-2138

MAT-US-2109597-v1.0-11/2021

 

 

9. PRODUCT SELECTION

Adacel® (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed)

Adlyxin® (lixisenatide) injection

Admelog® (insulin lispro injection) 100 Units/mL

Apidra® (insulin glulisine injection) 100 Units/mL

Imogam® Rabies-HT Immune Globulin, [Human] USP, Heat Treated

Imovax® Rabies Vaccine [Human Diploid Cell]

Lantus® (insulin glargine injection) 100 Units/mL

Lovenox® (enoxaparin sodium injection)*1

Menactra® Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diptheria Toxoid Conjugate Vaccine

Mozobil® (plerixafor injection)1

APPLICATION

Multaq® (dronedarone) Tablets*

Pentacel® Diptheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine

Priftin® (rifapentine) Tablets

Soliqua® 100/33 (insulin glargine & lixisenatide) injection 100 Units/mL and 33 mcg/mL

Tenivac® (tetanus and diphtheria toxoids adsorbed)

Thymoglobulin® [Anti-Thymocyte Globulin (Rabbit)]*,1

Toujeo® (insulin glargine injection) 300 Units/mL (1.5 mL or 3.0 mL pens)**

*Please see full U.S. prescribing information, including Black Box warning.

**Regular SoloStar® is packaged as 3 pens per pack 450 units/pen; dials up to 80 units per single injection. Max SoloStar® is packaged as 2 pens per pack 900 units/pen; dials up to 160 units per single injection; Max pen dials in 2-unit increments.

1If applying for Drug Replacement (Lovenox®, Mozobil®, and Thymoglobulin®), a copy of the claim, denial, flow sheet(s) and drug dispensing log (with patient name, date of service, product NDC/Lot #, total dosage) must be submitted.

Full U.S. prescribing information for all Sanofi Patient Connection supported products can be accessed at www.visitspconline.com. Sanofi Patient Connection will provide assistance for any medically appropriate use as described in the prescribing information.

10. WHAT DOES A SUCCESSFUL PATIENT ASSISTANCE CONNECTION APPLICATION LOOK LIKE?

To apply for Patient Assistance Connection all information must be complete and include the following:

Patient Information:

Complete all relevant information on page 2, and sign and date the Patient Authorization on page 3 (REQUIRED).

Healthcare Provider:

Ask your Healthcare Provider (HCP) to complete page 4 and sign and date it.

Ask your HCP to mail, fax, or submit through the Provider Portal your completed application.

Missing information may delay processing of application.

Do not include Patient Medical Records with this application.

11. ADDITIONAL INFORMATION

Sanofi Patient Connection ships most medications in a 90-day supply.

A representative from Sanofi may contact you for follow-up on any adverse event you may report regarding a Sanofi product.

12. FORM SUBMISSION OPTIONS

U.S. Mail

Fax

Sanofi Patient Connection

1.888.847.1797

PO Box 222138

 

Charlotte, NC 28222-2138

 

Do not include Patient Medical Records with this application.

© 2021 Sanofi US Services, Inc.

5 of 5

MAT-US-2109597-v1.0-11/2021

 

Secure Provider Portal*

www.visitspconline.com

*Excluding Mozobil® and Thymoglobulin®

P:1.888.847.4877 · F: 1.888.847.1797 P.O. Box 222138 · Charlotte, NC · 28222-2138

Document Specs

Fact Name Description
Program Overview Sanofi Patient Connection® provides access to select Sanofi prescription medications and vaccines at no cost for eligible U.S. residents as part of the Patient Assistance Connection, facilitated by Sanofi Cares North America.
Eligibility Requirements To be eligible, applicants must be U.S. or U.S. territory residents under the care of a licensed U.S. healthcare provider, meet specific income criteria, have no insurance or lack access to the prescribed product through insurance, and meet certain age requirements for vaccines.
Application Process Applicants must complete and sign the application, then have their healthcare provider complete and sign a portion of the form before submitting it through mail, fax, or the Secure Provider Portal (excluding Mozobil® and Thymoglobulin®).
Medication Delivery Approved medications are dispatched directly to the healthcare provider's office within approximately 5-7 business days.
Enrollment Duration Eligible patients are enrolled for 12 months, with specific adjustments for Medicare Part D patients to align with the calendar year.
Reapplication To continue receiving assistance after the initial enrollment period, participants must reapply and meet the current eligibility criteria.
Governing Law While the form does not specify state-specific governing laws, it indicates that healthcare providers must be authorized under state law to prescribe and dispense medication, suggesting that state regulations may influence program operations.

Instructions on Writing Sanofi Patient Assistance

After you've determined that you are eligible for the Sanofi Patient Assistance Connection, completing the application form is the next vital step towards gaining access to prescribed Sanofi medications and vaccines at no cost. Ensuring that every section of the application is filled out thoroughly and accurately is crucial for a smooth processing experience. Missing or incorrect information can lead to delays, so attentiveness to detail is key. Here are the steps you need to follow to correctly fill out the form.

  1. Fill in the Patient Information: On page 2 of the application, provide your personal details including your first and last names, gender, date of birth, Social Security Number (SSN), primary language, email, full address, phone number, household size, and annual income. Additionally, designate a patient representative if you would like someone to speak on your behalf regarding the application.
  2. Complete the Patient Insurance Information section: Indicate whether you have insurance and if it is Medicare Part D. Also, provide details on your primary and secondary insurance (if applicable), including the policy and group numbers, and the policyholder's name and date of birth.
  3. Indicate if you need help with Resource Connection: Check 'Yes' if you want the Program to identify additional resources for you, and select which types of resources you're interested in.
  4. Sign the Patient Authorization section (REQUIRED): Read the authorization text carefully, then sign and date the form to give Sanofi Patient Connection permission to process your application based on the information provided, including conducting an income verification process that won't affect your credit score.
  5. Address the Patient Consent section: Sign and date to consent to being contacted with information about the program, disease states, products promotions, services, and research studies after de-identifying your health information.
  6. Have your Healthcare Provider (HCP) complete their part of the application: This includes the Treatment and Prescribing Information along with the Prescriber Information. Ensure that your HCP signs and dates the application to confirm the necessity of the prescribed Sanofi medication for your medical condition.
  7. Select the products you are applying for assistance with in the Product Selection section.

After completing the form, review it with your healthcare provider to ensure all information is accurate and no sections are missed. Your HCP can then submit the application through mail, fax, or the Secure Provider Portal, except for applications involving Mozobil® and Thymoglobulin®. Keep a copy for your records and await confirmation of your enrollment from Sanofi, after which your medications will be shipped directly to your healthcare provider's office.

Understanding Sanofi Patient Assistance

What is the Sanofi Patient Connection Program?

The Sanofi Patient Connection Program is a comprehensive support initiative designed to help individuals access Sanofi medications and resources at no cost. This patient assistance component of the Program provides select Sanofi prescription medications and vaccines free of charge, subject to eligibility criteria. The Program operates out of Sanofi Cares North America and aims to assist eligible U.S. residents and those in U.S. territories who are under the care of a licensed healthcare provider.

Who is eligible for the Patient Assistance Connection?

To be eligible for this part of the Program, applicants must be U.S. or U.S. territory residents receiving care from a healthcare provider licensed to prescribe, dispense, and administer medicine in the U.S. Their annual household income must be at or below 400% of the current Federal Poverty Level. Eligibility also depends on the applicant's insurance status—those with no insurance coverage, commercially insured patients without access to the prescribed product or treatment through their insurance, or Medicare Part D enrollees meeting the income criteria may qualify. For vaccine assistance, applicants must be 19 years of age or older, with specific exceptions noted.

How does one apply for assistance through the Program?

Applicants must complete and sign the application form, ensuring all relevant information is accurately provided. The healthcare provider must then complete their portion of the form and also sign it. Completed applications can be submitted by mail, fax, or through the Secure Provider Portal (with certain product exceptions). It is crucial to provide all requested information to avoid delays in the processing of the application.

What occurs after an application is submitted?

Upon receipt of a completed application, it undergoes a review process to determine the applicant's eligibility. Approved applicants and their healthcare providers are informed via a letter about enrollment, which lasts for 12 months—or through the end of the calendar year for Medicare Part D patients. Medications are then shipped directly to the healthcare provider’s office within 5-7 business days. If an application is denied, a letter explaining the reason for the denial will be sent.

Does applying to the Program affect one’s credit score?

No, applying to the Sanofi Patient Connection Program does not affect the applicant’s credit score. The Program may perform a soft credit inquiry as part of income verification during the eligibility determination process, which does not impact credit scoring.

Can changes in financial or insurance status affect Program eligibility?

Yes, participants are responsible for informing the Program representative and their healthcare provider immediately if there are any changes in income or insurance status during their participation. Such changes could potentially affect eligibility for assistance through the Program.

Common mistakes

When completing the Sanofi Patient Assistance form, people often make crucial mistakes that can lead to delays or even denial of assistance. One common mistake is incompletely filling out the patient information section. Every piece of requested information, including contact details and household size, is essential for determining eligibility. Overlooking even a single field may result in the application being flagged for additional information, thereby delaying the process.

Another significant error is neglecting to provide complete insurance information. The form requires details of any existing insurance, including Medicare Part D coverage. Failure to accurately disclose insurance status or incorrectly indicating Medicare Part D coverage can mislead the reviewing committee about the applicant's true eligibility, particularly given that specific criteria apply depending on insurance status. This step is crucial, especially for those with limited or no insurance, as it directly impacts eligibility evaluation.

A further mistake involves the documentation of Medicaid denial for those who could potentially qualify for Medicaid. Applicants sometimes forget to attach or fail to obtain this necessary document. Given that eligibility for the Sanofi program requires proof of Medicaid denial for those who might qualify, skipping this step can halt the application process entirely, preventing those in need from accessing vital medication.

Many applicants also overlook the resource connection section, which is designed to identify additional support services that the applicant may benefit from. Failure to indicate interest in these resources means missing out on potentially valuable assistance with transportation, nutritional supplements, and more, beyond the prescription assistance sought.

Lastly, a common oversight is the failure to properly complete the healthcare provider's section and ensuring their signature is on the form. This portion is essential as it contains verification of the medical need for Sanofi products and confirms the healthcare provider’s role in the applicant’s care. An application missing the healthcare provider's detailed information and signature will not be processed, as this is a mandatory step in verifying the necessity and appropriateness of the requested medication for the patient.

Documents used along the form

When applying for the Sanofi Patient Assistance Connection, a thorough and accurate submission of required forms and supporting documents ensures a swift and favorable review process. It's essential to understand the myriad of documents that often accompany or are requested along with the Sanofi Patient Assistance form to bolster an application. Below is a list of such documents, each serving its unique purpose in the application process:

  • Proof of Income: Documentation such as recent pay stubs, tax returns, or a W-2 form, which verifies the applicant's annual household income.
  • Proof of Residence: Items such as utility bills, a rental agreement, or a state ID can serve as proof the applicant resides within the U.S. or U.S. territories.
  • Insurance Denial Letter: For those who might be eligible for Medicaid, a formal denial letter must be provided to demonstrate that Medicaid coverage is not available.
  • Medicare Part D Documentation: If enrolled in Medicare Part D, documents proving enrollment are necessary, potentially influencing eligibility based on income criteria.
  • Prescription Information: A detailed prescription from the healthcare provider, including medication name, dosage, and frequency of use.
  • Authorization for Release of Information: This form allows Sanofi Patient Connection to obtain and verify personal, medical, and financial information for program eligibility purposes.
  • Healthcare Provider’s Statement: A document from the healthcare provider that includes verification of the medical necessity for the requested medication.
  • Government Issued ID: A copy of an identification card, such as a driver’s license or passport, to help identify the applicant.
  • Patient Consent Form: Similar to the Authorization for Release of Information but specifically allows for contact and follow-up regarding the program, adverse events, and potentially for research purposes.
  • Additional Support Program Applications: For applicants seeking additional resources, such as clinical support services or nutritional supplement assistance, related forms are required.

Adequately preparing and submitting the appropriate documents alongside the Sanofi Patient Assistance form can expedite the processing time and facilitate access to the necessary medications. It's imperative to review each document for accuracy and completeness before submission to avoid delays. More information on the requirements for each of these documents can usually be found within the application instructions or by contacting the program directly.

Similar forms

The Sanofi Patient Assistance form shares similarities with the Pfizer Patient Assistance Program Application form. Both are designed to offer medications at no cost to eligible patients who cannot afford them. These applications require detailed personal, medical, and financial information to determine eligibility, emphasizing their aim to support those in financial need. Each form demands a healthcare provider’s involvement, ensuring the medication requested is medically necessary. This process includes physician certification regarding the patient's health status and the prescribing information, underlining the safeguard mechanisms to ensure appropriate and justified patient assistance.

Comparable to the Merck Patient Assistance Program Enrollment Form, the Sanofi form mandates detailed insurance information and a segment dedicated to verifying patient eligibility for other government or insurance benefits. Both forms scrutinize the patient's insurance status to ensure the program supports those most in need, particularly targeting individuals without insurance coverage or those ineligible to claim their prescribed medication through insurance. Such forms highlight a multi-tiered approach to patient assistance, prioritizing an exhaustive eligibility check to focus aid on underinsured or uninsured individuals.

Similar to the Novartis Patient Assistance Foundation Application, the Sanofi form includes a patient consent section for the use and disclosure of health information. This section is crucial for compliance with privacy laws and guidelines, such as the Health Insurance Portability and Accountability Act (HIPAA). It permits the collection, use, and disclosure of personal and health information for program administration purposes. This parallel shows an industry standard in handling sensitive patient data, ensuring participants understand their privacy rights and the scope of consent.

The Lilly Cares Foundation Patient Assistance Program application is akin to the Sanofi form in its requirement for comprehensive treatment and prescribing information. Both applications necessitate details on the medication prescribed, dosage, and treatment duration, supplied by the healthcare provider. This ensures the assistance provided aligns precisely with the patient’s needs while streamlining the process to prevent any unnecessary delays in receiving aid. This approach underscores the programs’ commitment to delivering targeted support to patients.

Like the Amgen Safety Net Foundation application, the Sanofi form solicits a signed patient authorization, underscoring the importance of informed consent in the patient assistance process. This legally binding section ensures patients are fully aware of the terms, conditions, and the scope of the assistance program, including how their information will be used. This mutual understanding fosters transparency between the patient, healthcare provider, and the pharmaceutical company, establishing a trust foundation vital for such assistance programs.

The HealthWell Foundation’s application for assistance bears resemblance to the Sanofi form in its provisions for emergency shipments or expedited processing for urgent cases. While not explicitly stated in every section of the Sanofi form, the streamlined process for receiving medication—direct shipping to healthcare providers' offices—hints at a structure designed to minimize delays in patient care. This reflects a shared industry focus on ensuring timely access to medications for those in critical need, underscoring the humanitarian goals underpinning these programs.

Lastly, the Assistance Foundation for Accessible Medications application parallels the Sanofi form in its segment offering additional resources beyond the primary assistance scope. Both provide options for patients to indicate interest in supplementary support services, including disease education and support for insurance navigation. This holistic approach to patient aid reflects a broader understanding of the challenges facing individuals with chronic or serious illnesses, acknowledging that medication access is only one aspect of comprehensive care.

Dos and Don'ts

Filling out the Sanofi Patient Assistance form accurately and completely is crucial to accessing needed medications and resources at no cost. Here are some key dos and don'ts to help guide you through the process:

Dos:
  • Do ensure that you meet the eligibility requirements before applying, including residency, income level, and insurance status.
  • Do read all instructions carefully to understand the application process thoroughly.
  • Do complete all sections of the form with accurate and current information.
  • Do sign and date the patient authorization and consent sections as required.
  • Do have your healthcare provider complete their section of the form to certify that the medication is necessary.
  • Do double-check that your healthcare provider has included their license information and the facility address.
  • Do include your household size and income information accurately to assist with the eligibility assessment.
  • Do consider opting in for additional assistance provided by the program, such as resource connection services.
  • Do make sure your application is submitted through the correct channel (mail, fax, or online portal).
  • Do follow up with Sanofi Patient Connection if you have any questions or concerns about your application or the process.
Don'ts:
  • Don't leave any sections blank. Incomplete applications may result in processing delays or denial of assistance.
  • Don't submit incomplete or inaccurate documentation. Ensure all required fields are filled out and that your information is correct.
  • Don't include patient medical records with your application, as they are not required and could compromise privacy.
  • Don't forget to review your application for errors before submitting it to ensure everything is filled out correctly.
  • Don't ignore the patient consent or authorization sections; your signature and agreement are necessary for processing.
  • Don't hesitate to ask for help from your healthcare provider if you're unsure about any information required on the form.
  • Don't overlook the details about your insurance information if applicable, including whether you have Medicare Part D.
  • Don't submit the form without first verifying if you may be eligible for Medicaid and providing documentation of Medicaid denial if required.
  • Don't fail to inform Sanofi Patient Connection if your income or insurance status changes during your enrollment in the program.
  • Don't attempt to apply for medications not covered under the Sanofi Patient Assistance Connection program.

Misconceptions

Here are four common misconceptions about the Sanofi Patient Assistance form and clarifications for each:

  • Eligibility is only based on income: While household income (≤400% of the Federal Poverty Level) is a significant factor, eligibility also requires being a U.S. resident or living in U.S. territories, being under the care of a licensed U.S. healthcare provider, and lacking insurance coverage or access to the prescribed treatment. For vaccines, age requirements must also be met.
  • Medicare Part D enrollees are ineligible: This is incorrect. Patients enrolled in Medicare Part D might still qualify for assistance under this program, provided they meet the specific income criteria outlined for eligibility. It is important to review the eligibility criteria carefully, as they accommodate a wider group of patients than some might assume.
  • The application process is overly complicated: The process is clearly structured. Applicants must complete and sign the patient information and authorization sections, and have their healthcare provider complete the relevant section and submit the application. While the requirement for comprehensive information might seem daunting, the application is designed to ensure eligible patients can access the medications they need.
  • Assistance only covers medication costs: The Sanofi Patient Assistance Connection provides more than just free medication. Eligible patients can also access resources and support services. This holistic approach ensures patients receive the comprehensive care and support necessary for effective treatment management.

Key takeaways

When applying for the Sanofi Patient Assistance Connection, it's crucial to understand the key elements that make the application process smooth and ensure access to necessary medications. Here are pivotal takeaways to guide applicants through this process:

  • Eligibility Criteria: Applicants must be U.S. residents or residents of U.S. territories, under the care of a licensed healthcare provider in the U.S., have a household income ≤400% of the Federal Poverty Level, and lack insurance coverage or have no access to their prescribed Sanofi medication through their insurance. Specific criteria for Medicare Part D enrollees and vaccine requirements based on age are also detailed.
  • Application Process: To apply, the patient must complete the first section of the application and provide a signature on the third page. The healthcare provider is required to fill out and sign the fourth page. Any missing information can delay the application process.
  • Submission Methods: Completed applications can be submitted via U.S. Mail, fax, or through a Secure Provider Portal, except for applications related to Mozobil® and Thymoglobulin®.
  • Review and Notification: After submission, Sanofi will review the application to determine eligibility. Both the patient and the healthcare provider will be notified. Medicare Part D patients also involve notification of their plan sponsor.
  • Enrollment Duration: Eligible patients are enrolled for 12 months, or through the end of the calendar year for Medicare Part D patients. Medications are delivered to the healthcare provider’s office within approximately 5-7 business days upon approval.
  • Mandatory Authorizations: The application includes sections requiring patient authorization and consent related to the use and disclosure of health information for program administration, contact preferences, and other uses as specified.
  • Prohibition on Medical Records Submission: Application guidelines specify that patient medical records should not be included with the application, emphasizing the importance of privacy and the focused nature of the required documentation.

Understanding and adhering to these key points can significantly impact the successful enrollment into the Sanofi Patient Assistance Connection, facilitating access to necessary medications for eligible patients.

Please rate Free Sanofi Patient Assistance Form in PDF Form
4.67
(Exceptional)
3 Votes

Additional PDF Templates